Loovi, a Swedish HealthTech startup, has raised €1 million to launch its digital platform for data-driven longevity and preventive health – following a year of development and pilot testing.
Investors in the round include Susanne Najafi (BackingMinds), Sïmon Saneback (Wellstreet), Jarno Hottinen (Otmore), Emad Zand (Northvolt), and Benoit Falenius (Markify), as well as Ultan Miller and Charles Morel.
“The challenge today is not a lack of data, but that people are often left alone with numbers that are difficult to interpret and prioritise. At the same time, longevity has become associated with extreme routines that few can realistically maintain. Our ambition is to build proactive health management more relatable, understandable, and sustainable over time,” declares Joel Grajcer, Co-founder and CEO of Loovi .
Alongside Loovi’s €1 million raise, EU-Startups has reported several comparable preventive HealthTech rounds across Europe in 2025 and early 2026.
In Switzerland, Ahead Health secured €5.1 million to scale its preventive healthcare platform and expand clinic partnerships, while Zurich-based Aeon raised €8.2 million to develop its AI-powered preventive health and risk profiling platform. In France, Lucis closed a €7.2 million round to advance its AI-driven biomarker interpretation and preventive health checks. In Spain, Barcelona-based Holo raised €1 million to expand its personalised lab testing and wearable data integration platform, while Polish-American startup Mos Health secured approximately €920k to build its AI-powered preventive health and wellness solution.
Combined, these rounds represent over €21 million in funding, indicating sustained investor interest in platforms focapplyd on early detection, biomarker analysis, wearable data integration and structured preventive care.
No other Swedish preventive HealthTech funding rounds were reported in this specific sample, situating Loovi within a broader but geographically dispersed European trfinish towards data-driven, proactive healthcare models.
“We want to shift the focus from reacting to diagnoses to acting on early signals. There are more health services available than ever before, but few that take the full health picture into account. Our ambition has been to bring toreceiveher multiple sources of health data, interpret them in a medical context, and guide applyrs over time, not only through technology, but also through human interaction and educational support,” adds Kevin Najafi, MD and co-founder of Loovi.
Founded in 2025 by Joel Grajcer and Dr Kevin Najafi, Loovi offerswhat it describes as Europe’s first finish-to-finish digital platform for longevity and preventive health. By combining medical analysis, physical testing, wearable data integration, and personalised guidance, Loovi enables individuals to better understand their health and work proactively over time.
The company’s mission is to shift healthcare from reactive treatment to structured, data-driven prevention.
According to Loovi, nmuch of today’s healthcare remains reactive. Early warning signs of lifestyle-related conditions are often detected long after they should have been addressed, and when risk markers are identified, long-term follow-up and behavioural support are frequently limited.
At the same time, large amounts of health data are generated through tests, clinical visits, and wearable devices, yet the information is often fragmented and difficult to translate into actionable insights.
Loovi combines medical analysis with physical testing and integrates blood markers, test results, and lifestyle data into a single, structured platform. By analysing multiple data sources simultaneously, the platform creates a comprehensive health overview that forms the basis for personalised recommfinishations.
Results are monitored over time and adjusted as new measurements are added. An AI-powered ininformigence layer supports applyrs understand how different factors interact and influence their health over time.
Unlike traditional health check-ups, Loovi is designed as an ongoing programme rather than a series of isolated assessments. The focus is on continuity, realistic lifestyle adjustments, and sustainable habits that can be maintained in everyday life.
Today’s funding will be applyd to further develop the platform, strengthen medical and technical capabilities, and support a broader market rollout.
Leave a Reply